CompoAtlas

Estroven Maximum Strength

Natural health product licensed in Canada

Licence holder
i-Health Inc.
NPN or DIN-HM
80032569
Status
Inactive licence
Licence date
1 June 2012
Revision date
31 July 2013
Form
Comprimé
Route of administration
Orale
Application type
Non traditionnelle

If this product were sold in France

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
1,3,7-Triméthylxanthine49 mgNot calculated
3-Pyridinecarboxamide

Source : Niacinamide

20 mgNot calculated
Cimicifuga racemosa

Source : Extrait de racine

Extraction ratio : 6:1

Dry plant equivalent : 480 mg

80 mgNot calculated
L-théanine

Source : N-ethyl-L-glutamine

50 mgNot calculated
Vitex agnus-castus

Source : Fruit

Extraction ratio : 12:1

Dry plant equivalent : 900 mg

75 mgNot calculated
Vaccinium macrocarpon

Source : Fruit

Extraction ratio : 12:1

Dry plant equivalent : 300 mg

25 mgNot calculated
Vitamine D

Source : Cholécalciférol

25 mcgNot calculated
Boron

Source : Glycinate de Bore

1.5 mgNot calculated
Vitamine E

Source : D-alpha-tocophéryl succinate

20.1 mg ATNot calculated
Vitamine B6

Source : Chlorhydrate de pyridoxine

20 mgNot calculated
Chrome

Source : Chromium bisglycinate

120 mcgNot calculated
Folate

Source : Acide folique

400 mcgNot calculated

Non-medicinal ingredients

Dioxyde de titane, Hydroxypropylcellulose, Microcrystalline cellulose, propylèneglycol, Hypromellose, Silice, Croscarmellose de sodium, Acide stéarique, Poly(éthylène glycol), citrate de sodium

PopulationAgeQuantity per servingFrequency
Femmes ménopausées et en postménopauseNot specified1 Comprimé1 Tous les jours

Uses authorised in Canada

Text supplied in English because no French text is available.

Clinically shown to help relieve symptoms associated with menopause. Helps to reduce hot flashes. Also helps in the development and maintenance of bones and teeth, in the absorption and use of calcium and phosphorus and to prevent Vitamin D deficiency. Calcium intake, when combined with sufficient vitamin D, a healthy diet, and regular exercise, may reduce the risk of developing osteoporosis.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Warnings are available in English on the official record.

Source

Official Health Canada record, licence 80032569

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).

List recorded in 2013. Photograph the packaging to check whether it has changed. Photograph the packaging

List recorded in 2013. Photograph the packaging to check whether it has changed.

Enter to analyse, Shift+Enter for a new line